{"id":60084,"date":"2024-10-01T12:05:40","date_gmt":"2024-10-01T12:05:40","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/10\/01\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/"},"modified":"2024-10-01T12:05:40","modified_gmt":"2024-10-01T12:05:40","slug":"catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/","title":{"rendered":"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024"},"content":{"rendered":"<div>\n<p align=\"justify\">CORAL GABLES, Fla., Oct.  01, 2024  (GLOBE NEWSWIRE) &#8212; Catalyst Pharmaceuticals, Inc. (&#8220;Catalyst&#8221; or &#8220;Company&#8221;) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst&#8217;s management team, will participate in the upcoming BofA Securities CNS Therapeutics Virtual Conference 2024 on Monday, October 7, 2024.<\/p>\n<p><strong>Presentation Details:<\/strong><\/p>\n<table style=\"border-collapse: collapse; border-collapse:collapse ;\">\n<tr>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \"><strong>Presentation:<\/strong><\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0 \u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">Monday, October 7, 2024<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \"><strong>Time:<\/strong><\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">9:50 am ET<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\" style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \"><strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FI0D2tzc9-4uzcKIj2KdAC-rrQl1ILyMp73D1nKnHSlegvBuJ1kGxBVaqogjnQK-cbR85qpdDCZH7oeFJK74IPl-b5KjRE3ZzQzB-9srpz4qLW7eTnpQ3_Vdez1VGPE2yEGHnvCam0MY6c2xyDC30ClfkOIyfKqCtSkyESZOS-iS96R7555qysp3qniKEOd6oFGV3rTazQzxVyBGfHPq6YgXu7foG6oCrLtx2AwaGOQmmBr2Jj2g2ZYfGOw008VI2d5ZIi49l9F4n0nJpyg3KgdgCuwZf07CpRdbePVc1NHIqDySs_h-ve2bPpMc4MjSURFcwIpnUujINilD5iJH7B9JE8Ir2MxtHrK0lMTy4gtkY-FxhZNo7r96BjxcP--5b-raKQ_tVbDa3onwptSVPg==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Webcast Link\">Webcast Link<\/a><\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: left ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>The webcast will be available under the Investors section on the Company&#8217;s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d5QZZ26MjBOm32YqkdXo1nAcSSmPFIBKwG3ywJhofnWabrdX74cIDazPMcAFopDSC0UP3ivn01qpnGTSrc5kb-cvH_Qys_5j0-QTgBz-Zfs=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.catalystpharma.com\">www.catalystpharma.com<\/a>, and a replay will be available for at least 30 days.<\/p>\n<p align=\"justify\"><strong>About\u00a0Catalyst Pharmaceuticals<\/strong><br \/>Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track record of bringing life-changing treatments to the market, we focus on in-licensing, commercializing, and developing innovative therapies. Guided by our deep commitment to patient care, we prioritize accessibility, ensuring patients receive the care they need through a comprehensive suite of support services designed to provide seamless access and ongoing assistance. Catalyst maintains a well-established U.S. presence while actively seeking to expand its global commercial footprint through strategic partnerships. Catalyst is headquartered in Coral Gables, FL., and was recognized on the Forbes 2024 list as one of America&#8217;s most successful small-cap companies.<\/p>\n<p align=\"justify\">For more information, please visit Catalyst&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d5QZZ26MjBOm32YqkdXo1nAcSSmPFIBKwG3ywJhofnX-d2tjOpQ0oOWJtsNpVvwBEqo0h_uKjVvdTf2GpzBhnJaJB_XAdIu_vxkoBItAi3w=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.catalystpharma.com\">www.catalystpharma.com<\/a>.\u00a0<\/p>\n<p align=\"justify\"><strong>Forward-Looking Statements<\/strong><br \/>This press release contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst&#8217;s actual results in future periods to differ materially from forecasted results. A number of factors, including those factors described in Catalyst&#8217;s Annual Report on Form 10-K for the fiscal year 2023 and its other filings with the\u00a0U.S. Securities and Exchange Commission\u00a0(&#8220;SEC&#8221;), could adversely affect Catalyst. Copies of Catalyst&#8217;s filings with the\u00a0SEC\u00a0are available from the\u00a0SEC, may be found on Catalyst&#8217;s website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.<\/p>\n<p>Source: Catalyst Pharmaceuticals, Inc.<\/p>\n<pre>CONTACT: Investor Contact\r\nMary Coleman, Catalyst Pharmaceuticals, Inc.\r\n(305) 420-3200\r\nmcoleman@catalystpharma.com\r\n\r\nMedia Contact\r\nDavid Schull, Russo Partners\r\n(858) 717-2310\r\ndavid.schull@russopartnersllc.com<\/pre>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NWY3ZGUxNzMtNTgwYi00N2Q4LWI5YzMtMDk1YjMxN2FjNWFkLTEwMzEwMzE=\/tiny\/Catalyst-Pharmaceuticals-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) &#8212; Catalyst Pharmaceuticals, Inc. (&#8220;Catalyst&#8221; or &#8220;Company&#8221;) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst&#8217;s management [&#8230;]\n","protected":false},"author":1,"featured_media":60085,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-60084","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024 - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024\" \/>\n<meta property=\"og:description\" content=\"CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) &#8212; Catalyst Pharmaceuticals, Inc. (&#8220;Catalyst&#8221; or &#8220;Company&#8221;) (Nasdaq: C\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-01T12:05:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/Catalyst-Pharmaceuticals-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024\",\"datePublished\":\"2024-10-01T12:05:40+00:00\",\"dateModified\":\"2024-10-01T12:05:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/\",\"name\":\"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024 - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-10-01T12:05:40+00:00\",\"dateModified\":\"2024-10-01T12:05:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024 - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/","og_locale":"en_US","og_type":"article","og_title":"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024","og_description":"CORAL GABLES, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) &#8212; Catalyst Pharmaceuticals, Inc. (&#8220;Catalyst&#8221; or &#8220;Company&#8221;) (Nasdaq: C","og_url":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-10-01T12:05:40+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/Catalyst-Pharmaceuticals-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024","datePublished":"2024-10-01T12:05:40+00:00","dateModified":"2024-10-01T12:05:40+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/"},"wordCount":382,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/","url":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/","name":"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024 - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-10-01T12:05:40+00:00","dateModified":"2024-10-01T12:05:40+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/catalyst-pharmaceuticals-to-participate-in-the-bofa-securities-cns-therapeutics-virtual-conference-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=60084"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60084\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/60085"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=60084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=60084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=60084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}